Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer. - Wikidata - awgldk - TriplyDB

Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer.

Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer.

http://www.wikidata.org/entity/Q36977519

about

A phase I dose escalation study of S-1 with concurrent radiotherapy in elderly patients with esophageal cancer Definitive concurrent chemoradiotherapy with S-1 and cisplatin in elderly esophageal squamous cell carcinoma patients.Radio(chemo)therapy in Elderly Patients with Esophageal Cancer: A Feasible Treatment with an Outcome Consistent with Younger Patients.Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomes Is there a benefit in receiving concurrent chemoradiotherapy for elderly patients with inoperable thoracic esophageal squamous cell carcinoma?Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric Assessment.Health related quality of life after oesophagectomy: elderly patients refer similar eating and swallowing difficulties than younger patients.Feasibility of Elective Nodal Irradiation (ENI) and Involved Field Irradiation (IFI) in Radiotherapy for the Elderly Patients (Aged ≥ 70 Years) with Esophageal Squamous Cell Cancer: A Retrospective Analysis from a Single Institute Concurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer.Management and outcomes of localized esophageal and gastroesophageal junction cancer in older patients.Long-term results of definitive concurrent chemoradiotherapy using S-1 in the treatment of geriatric patients with esophageal cancer.Safety and efficacy of radiation and chemoradiation in patients over 70 years old with inoperable esophageal squamous cell carcinoma.Concomitant chemo-radiotherapy for unresectable oesophageal cancer: A mono-institutional study on 40 patients.Clinical prognostic factors for locally advanced esophageal squamous carcinoma treated after definitive chemoradiotherapy.Short- and long-term outcomes of definitive chemoradiotherapy in patients with esophageal carcinoma aged ≥75 years.Safety and outcome of external beam radiation and neutron brachytherapy in elderly patients with esophageal squamous cell cancer.Management of localized esophageal cancer in the older patient Geriatric assessment factors are associated with mortality after hospitalization in older adults with cancer.Multicenter questionnaire survey on patterns of care for elderly patients with esophageal squamous cell carcinoma by the Japan Esophageal Oncology Group.Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.Value of Percutaneous Radiologic Gastrostomy for Patients with Advanced Esophageal Cancer.Primary radio(chemo)therapy for esophageal cancer in elderly patients: are efficiency and toxicity comparable with younger patients?On the Receiving End of Autonomy and Law.Clinical Outcome of Esophagectomy in Elderly Patients With and Without Neoadjuvant Therapy for Thoracic Esophageal Cancer.Comparison of definitive chemoradiotherapy and radiotherapy alone in patients older than 75 years with locally advanced esophageal carcinoma: A retrospective cohort study.External beam radiation and high-dose-rate brachytherapy for elderly patients with gastroesophageal junction adenocarcinoma.Is surgery in the elderly for oesophageal cancer justifiable? Results from a single centre Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: an alternative to surgery?Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group.Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database.S-1 versus S-1 plus cisplatin concurrent intensity modulated radiation therapy in the treatment of esophageal squamous cell carcinoma: Study protocol for a randomized controlled phase II trial.Radiotherapy Alone or Concurrent Chemoradiation for Esophageal Squamous Cell Carcinoma in Elderly Patients.A phase II study of S-1 with concurrent radiotherapy in elderly patients with esophageal cancer.Feasibility and efficiency of concurrent chemoradiotherapy with capecitabine and cisplatin versus radiotherapy alone for elderly patients with locally advanced esophageal squamous cell carcinoma: Experience of two centers.Outcome of esophageal cancer in the elderly - systematic review of the literature.Radiotherapy in elderly patients with inoperable esophageal cancer. Is there a benefit?Esophagectomy in elderly patients: which is the best prognostic score?Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis.Advances in radiotherapy for esophageal cancer.Effects of S-1 combined with radiotherapy in the treatment of advanced esophageal cancer: A systematic review and meta-analysis protocol.

P2860

Q33431507-F58D14ED-36DA-416B-BBBE-28187269835D Q33571196-15A011D8-D529-4C6B-A5E7-F2CCC2B95E07 Q33633972-9F92BBE0-2C1F-4121-ABF1-FAD5A9F2B391 Q33702692-C825ECDF-D1DF-49E2-971E-05F40239AC3B Q34061742-BC149E48-A6DD-4351-A86A-6572FBFAC789 Q34306560-18A2A895-D31C-4DD5-A0CA-C6354A01DE58 Q35782325-2DBDA382-F23B-4E2C-AFC7-CBB206FD344F Q35860927-87E64AAC-C62F-484E-B3A9-17565E6D80BC Q36212799-C37F0F53-0FD1-4F46-B5C7-E97A3344AF7F Q36394599-127F556D-86D4-4816-AAB8-E9E907B5DC84 Q37252364-24F2C07A-6FD0-47D3-84C3-FAC4CEC8D001 Q37388685-41B4D834-DA9D-47AC-8D79-695AEF38F322 Q37392362-5B6F464A-A16E-4CB3-8146-7C40A2C840E6 Q37484572-EFFADA5C-3D5C-46AC-84F7-86B06D194806 Q37567853-07B7794D-AB94-4833-BA99-0A3F0D070BE7 Q37694563-CD3EF0D4-7BA1-4F06-96C2-187D57241572 Q37698187-9B91D14A-ED36-43BB-81C7-5042CF0024F9 Q38910410-AED7616A-4013-443E-8AC9-46678C3CD9C9 Q38930191-2165CE1B-CED7-4703-A9E7-E730D9120220 Q38984134-A47B5BC1-E25E-42D8-BA3C-79B55BC78A76 Q40671462-1C77A90F-09ED-4239-BE65-FF6A0020D2C4 Q40959170-2A49631C-0A02-4907-9FAA-3AAAD4C78B59 Q41064569-0BCC56A4-D9FA-4F2D-A1B6-BEB10EA2973D Q41532257-9E462971-9554-42E2-86CB-5F7341E5FDC9 Q41622068-D8EE4F4D-FA37-4F69-BD48-369D1B1E5C3D Q41689156-E2043D58-FFA2-4671-AB58-3DA672C48B41 Q42692684-3703780D-6CA5-45E0-A5AD-6ECE91B48E73 Q44247708-C4BA8055-FBEA-42C8-9822-11689304E544 Q45928400-0D9A5AD5-AA88-4703-862C-4F7D02E1A7B1 Q47128205-776D528E-E1E3-438A-86B9-7902D946EDA5 Q47129248-5D3E9CBB-37F7-4E8D-A843-5B3BD00353E1 Q47139282-C4A70777-269E-4765-9E05-F2BBD4841C8B Q47140726-71ACD6B0-64DD-454D-8AD5-2AB77BB1FADF Q47301455-AFD7086F-0112-44E3-B7B8-08BC12715DFD Q49837467-118120CD-E4B5-4D81-9364-916032210FB6 Q50967527-ABDB2BEE-4035-45B5-B087-24021B1CA0F4 Q53545059-0B76166C-CF42-42BE-A865-488D560A9308 Q55035451-71F3DF7B-C8DA-4889-9A1E-7685C2DD3665 Q55280639-8C80E10B-6D11-4CEE-B468-058A2A4BECB4 Q55344925-53976528-E41B-49B7-A08F-D157D62D2B85

P2860

Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer.

http://www.wikidata.org/entity/Q36977519

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Safety and outcome of definiti ...... ients with oesophageal cancer.

@en

type

label

Safety and outcome of definiti ...... ients with oesophageal cancer.

@en

prefLabel

Safety and outcome of definiti ...... ients with oesophageal cancer.

@en

P1433

Q36977519-CAC1DBAC-D351-4525-8471-F755725961E9

P1476

Q36977519-42C4CB1F-0230-43CC-A473-B595CB759B7D

P2093

Q36977519-5A01B19B-5B1D-4039-85FD-03E7B1D74EEB

Q36977519-62A3E127-081B-4E3E-8660-848890C91F17

Q36977519-8529AC36-B1F5-4CF9-9CF5-41958B613574

Q36977519-8DE95090-9E87-4025-83A4-3F9DA3C90840

Q36977519-C5D495FD-BEC9-4A08-813F-D8435CD55472

Q36977519-E0C33D8C-081D-4A1C-9286-A3F6A0A3B489

Q36977519-F15D49B6-F926-447A-AFBD-6175BF210C7C

P2860

Q36977519-0ECA56DD-2BEB-44E9-B495-4E4F83F16B6A

Q36977519-12D3C14A-368D-4637-B0B6-D244E0A8A662

Q36977519-1DBDCB55-7C88-4632-8F06-17044740406C

Q36977519-29AAB82D-2B26-4F65-8038-CE96392063F5

Q36977519-3C562400-598E-49CA-B71B-D2CFFFF050F9

Q36977519-64CC1C61-9052-4390-95A5-E1E1B8640FDA

Q36977519-67723270-5D91-40D2-B6A9-C6125A218969

Q36977519-680C952A-B1CC-47C2-85D2-3F22AE71508E

Q36977519-6D62BBC2-2318-46DF-BDE1-8738BC3EA985

Q36977519-81DDF561-D10B-43C8-87D2-B66336891422

P2888

Q36977519-7DB8A678-B0C6-4ED8-B34B-EB6953EEEAAE

P304

Q36977519-F8F573FD-AE2D-4B87-BC60-D1FB8A24269D

P31

Q36977519-F35817D5-A808-4B9E-87EB-8D93A86A5DF1

P356

Q36977519-6699E79A-A65C-4426-820B-74A949284A22

P407

Q36977519-58DA57BE-DEDD-43BE-A346-FB808EA09BFF

P433

Q36977519-8CD45C27-33F6-4CD3-8B6A-D2F293AF03AB

P478

Q36977519-EB7B4100-C38C-4FC8-AF46-B626FFF83F62

P50

Q36977519-CA7CB76E-2020-43BC-ACB4-C10BD5E3FF56

P577

Q36977519-45780B5A-D030-4D01-B715-7E3D170EA5B0

P5875

Q36977519-BB3A3DAC-902A-4931-82C1-1A22F925C581

P698

Q36977519-8D8DC264-6118-4219-823D-0B03A2AEB1EE

P921

Q36977519-71CFC6BA-A110-4990-A37B-BEFF6CAAFCDF

P932

Q36977519-19EC7EE4-A7CB-4873-8DDE-39975FF9E700

P356

P1433

British Journal of Cancer

P1476

Safety and outcome of definiti ...... tients with oesophageal cancer

@en

P2093

B Paillot

http://www.w3.org/2001/XMLSchema#string

F Di Fiore

http://www.w3.org/2001/XMLSchema#string

H Hamidou

http://www.w3.org/2001/XMLSchema#string

I Iwanicki-Caron

http://www.w3.org/2001/XMLSchema#string

N Berbera

http://www.w3.org/2001/XMLSchema#string

P Michel

http://www.w3.org/2001/XMLSchema#string

S Thureau

http://www.w3.org/2001/XMLSchema#string

P2860

Postoperative adjuvant chemoradiotherapy in older patients with head and neck cancer.

6-year experience of concurrent radiochemotherapy with vinorelbine plus a platinum compound in multimorbid or aged patients with inoperable non-small cell lung cancer.

Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma.

Global cancer statistics in the year 2000.

Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trials.

Combined modality chemoradiation in elderly oesophageal cancer patients.

Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial

Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy.

Chemoradiation in the management of esophageal cancer.

Endoscopic ultrasonography is an independent predictive factor of prognosis in locally advanced esophageal cancer. Results from the randomized FFCD 9102 study from the Fédération Francophone de Cancérologie Digestive.

P2888

P304

1586-1592

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6604749

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23466632

http://www.w3.org/2001/XMLSchema#string

P698

19002180

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

2584940

http://www.w3.org/2001/XMLSchema#string